Global Human Embryonic Stem Cells (HESC) Market Research Report 2023

Human embryonic stem cell: also known as a human pluripotent stem cell, one of the "cells that are self-replicating, are derived from human embryos or human fetal tissue, and are known to develop into cells and tissues of the three primary germ layers.

The global Human Embryonic Stem Cells (HESC) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Human Embryonic Stem Cells (HESC) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Human Embryonic Stem Cells (HESC) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Human Embryonic Stem Cells (HESC) include ESI BIO, Thermo Fisher, BioTime, MilliporeSigma (Merck), BD Biosciences, Astellas Institute of Regenerative Medicine, Asterias Biotherapeutics, PerkinElmer and Takara Bio, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Human Embryonic Stem Cells (HESC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Embryonic Stem Cells (HESC).

The Human Embryonic Stem Cells (HESC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Embryonic Stem Cells (HESC) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Embryonic Stem Cells (HESC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Human Embryonic Stem Cells (HESC)

1.2 Human Embryonic Stem Cells (HESC) Segment by Type

1.2.1 Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Type (2023-2029)

1.2.2 Totipotent Stem Cells

1.2.3 Pluripotent Stem Cells

1.2.4 Unipotent Stem Cells

1.3 Human Embryonic Stem Cells (HESC) Segment by Application

1.3.1 Global Human Embryonic Stem Cells (HESC) Market Value by Application: (2023-2029)

1.3.2 Research

1.3.3 Clinical Trials

1.3.4 Others

1.4 Global Human Embryonic Stem Cells (HESC) Market Size Estimates and Forecasts

1.4.1 Global Human Embryonic Stem Cells (HESC) Revenue 2018-2029

1.4.2 Global Human Embryonic Stem Cells (HESC) Sales 2018-2029

1.4.3 Global Human Embryonic Stem Cells (HESC) Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Manufacturers (2018-2023)

2.2 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Human Embryonic Stem Cells (HESC) Average Price by Manufacturers (2018-2023)

2.4 Global Human Embryonic Stem Cells (HESC) Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Product Type & Application

2.7 Human Embryonic Stem Cells (HESC) Market Competitive Situation and Trends

2.7.1 Human Embryonic Stem Cells (HESC) Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Human Embryonic Stem Cells (HESC) Players Market Share by Revenue

2.7.3 Global Human Embryonic Stem Cells (HESC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Human Embryonic Stem Cells (HESC) Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Human Embryonic Stem Cells (HESC) Global Human Embryonic Stem Cells (HESC) Sales by Region: 2018-2029

3.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Region: 2018-2023

3.2.2 Global Human Embryonic Stem Cells (HESC) Sales by Region: 2024-2029

3.3 Global Human Embryonic Stem Cells (HESC) Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2018-2029

3.3.1 Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2018-2023

3.3.2 Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2024-2029

3.4 North America Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country

3.4.1 North America Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029)

3.4.3 North America Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country

3.5.1 Europe Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029)

3.5.3 Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country

3.6.1 Asia Pacific Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029)

3.6.3 Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country

3.7.1 Latin America Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029)

3.7.3 Latin America Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029)

3.8.3 Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Human Embryonic Stem Cells (HESC) Sales by Type (2018-2029)

4.1.1 Global Human Embryonic Stem Cells (HESC) Sales by Type (2018-2023)

4.1.2 Global Human Embryonic Stem Cells (HESC) Sales by Type (2024-2029)

4.1.3 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2018-2029)

4.2 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2018-2029)

4.2.1 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2018-2023)

4.2.2 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2024-2029)

4.2.3 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2018-2029)

4.3 Global Human Embryonic Stem Cells (HESC) Price by Type (2018-2029)

5.1 Global Human Embryonic Stem Cells (HESC) Sales by Application (2018-2029)

5.1.1 Global Human Embryonic Stem Cells (HESC) Sales by Application (2018-2023)

5.1.2 Global Human Embryonic Stem Cells (HESC) Sales by Application (2024-2029)

5.1.3 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2018-2029)

5.2 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2018-2029)

5.2.1 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2018-2023)

5.2.2 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2024-2029)

5.2.3 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2018-2029)

5.3 Global Human Embryonic Stem Cells (HESC) Price by Application (2018-2029)

6.1 ESI BIO

6.1.1 ESI BIO Corporation Information

6.1.2 ESI BIO Description and Business Overview

6.1.3 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.1.4 ESI BIO Human Embryonic Stem Cells (HESC) Product Portfolio

6.1.5 ESI BIO Recent Developments/Updates

6.2 Thermo Fisher

6.2.1 Thermo Fisher Corporation Information

6.2.2 Thermo Fisher Description and Business Overview

6.2.3 Thermo Fisher Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Thermo Fisher Human Embryonic Stem Cells (HESC) Product Portfolio

6.2.5 Thermo Fisher Recent Developments/Updates

6.3 BioTime

6.3.1 BioTime Corporation Information

6.3.2 BioTime Description and Business Overview

6.3.3 BioTime Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.3.4 BioTime Human Embryonic Stem Cells (HESC) Product Portfolio

6.3.5 BioTime Recent Developments/Updates

6.4 MilliporeSigma (Merck)

6.4.1 MilliporeSigma (Merck) Corporation Information

6.4.2 MilliporeSigma (Merck) Description and Business Overview

6.4.3 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.4.4 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product Portfolio

6.4.5 MilliporeSigma (Merck) Recent Developments/Updates

6.5 BD Biosciences

6.5.1 BD Biosciences Corporation Information

6.5.2 BD Biosciences Description and Business Overview

6.5.3 BD Biosciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.5.4 BD Biosciences Human Embryonic Stem Cells (HESC) Product Portfolio

6.5.5 BD Biosciences Recent Developments/Updates

6.6 Astellas Institute of Regenerative Medicine

6.6.1 Astellas Institute of Regenerative Medicine Corporation Information

6.6.2 Astellas Institute of Regenerative Medicine Description and Business Overview

6.6.3 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product Portfolio

6.6.5 Astellas Institute of Regenerative Medicine Recent Developments/Updates

6.7 Asterias Biotherapeutics

6.6.1 Asterias Biotherapeutics Corporation Information

6.6.2 Asterias Biotherapeutics Description and Business Overview

6.6.3 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product Portfolio

6.7.5 Asterias Biotherapeutics Recent Developments/Updates

6.8 PerkinElmer

6.8.1 PerkinElmer Corporation Information

6.8.2 PerkinElmer Description and Business Overview

6.8.3 PerkinElmer Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.8.4 PerkinElmer Human Embryonic Stem Cells (HESC) Product Portfolio

6.8.5 PerkinElmer Recent Developments/Updates

6.9 Takara Bio

6.9.1 Takara Bio Corporation Information

6.9.2 Takara Bio Description and Business Overview

6.9.3 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Takara Bio Human Embryonic Stem Cells (HESC) Product Portfolio

6.9.5 Takara Bio Recent Developments/Updates

6.10 Fujifilm Cellular Dynamics

6.10.1 Fujifilm Cellular Dynamics Corporation Information

6.10.2 Fujifilm Cellular Dynamics Description and Business Overview

6.10.3 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product Portfolio

6.10.5 Fujifilm Cellular Dynamics Recent Developments/Updates

6.11 Reliance Life Sciences

6.11.1 Reliance Life Sciences Corporation Information

6.11.2 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Description and Business Overview

6.11.3 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product Portfolio

6.11.5 Reliance Life Sciences Recent Developments/Updates

6.12 R&D Systems (Biotrchne)

6.12.1 R&D Systems (Biotrchne) Corporation Information

6.12.2 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Description and Business Overview

6.12.3 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.12.4 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product Portfolio

6.12.5 R&D Systems (Biotrchne) Recent Developments/Updates

6.13 STEMCELL Technologies

6.13.1 STEMCELL Technologies Corporation Information

6.13.2 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Description and Business Overview

6.13.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.13.4 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product Portfolio

6.13.5 STEMCELL Technologies Recent Developments/Updates

6.14 TATAA Biocenter

6.14.1 TATAA Biocenter Corporation Information

6.14.2 TATAA Biocenter Human Embryonic Stem Cells (HESC) Description and Business Overview

6.14.3 TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.14.4 TATAA Biocenter Human Embryonic Stem Cells (HESC) Product Portfolio

6.14.5 TATAA Biocenter Recent Developments/Updates

6.15 UK Stem Cell Bank

6.15.1 UK Stem Cell Bank Corporation Information

6.15.2 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Description and Business Overview

6.15.3 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.15.4 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product Portfolio

6.15.5 UK Stem Cell Bank Recent Developments/Updates

6.16 Viacyte, Inc.

6.16.1 Viacyte, Inc. Corporation Information

6.16.2 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Description and Business Overview

6.16.3 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023)

6.16.4 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product Portfolio

6.16.5 Viacyte, Inc. Recent Developments/Updates

7.1 Human Embryonic Stem Cells (HESC) Industry Chain Analysis

7.2 Human Embryonic Stem Cells (HESC) Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Embryonic Stem Cells (HESC) Production Mode & Process

7.4 Human Embryonic Stem Cells (HESC) Sales and Marketing

7.4.1 Human Embryonic Stem Cells (HESC) Sales Channels

7.4.2 Human Embryonic Stem Cells (HESC) Distributors

7.5 Human Embryonic Stem Cells (HESC) Customers

8.1 Human Embryonic Stem Cells (HESC) Industry Trends

8.2 Human Embryonic Stem Cells (HESC) Market Drivers

8.3 Human Embryonic Stem Cells (HESC) Market Challenges

8.4 Human Embryonic Stem Cells (HESC) Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Human Embryonic Stem Cells (HESC) Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Human Embryonic Stem Cells (HESC) Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Human Embryonic Stem Cells (HESC) Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Human Embryonic Stem Cells (HESC) Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Human Embryonic Stem Cells (HESC), Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Product Type & Application

    Table 12. Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Human Embryonic Stem Cells (HESC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Embryonic Stem Cells (HESC) as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Human Embryonic Stem Cells (HESC) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Human Embryonic Stem Cells (HESC) Sales by Region (2018-2023) & (K Units)

    Table 18. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2018-2023)

    Table 19. Global Human Embryonic Stem Cells (HESC) Sales by Region (2024-2029) & (K Units)

    Table 20. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2024-2029)

    Table 21. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2018-2023)

    Table 23. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2024-2029)

    Table 25. North America Human Embryonic Stem Cells (HESC) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Human Embryonic Stem Cells (HESC) Sales by Country (2018-2023) & (K Units)

    Table 27. North America Human Embryonic Stem Cells (HESC) Sales by Country (2024-2029) & (K Units)

    Table 28. North America Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Human Embryonic Stem Cells (HESC) Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Human Embryonic Stem Cells (HESC) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Human Embryonic Stem Cells (HESC) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Human Embryonic Stem Cells (HESC) Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Human Embryonic Stem Cells (HESC) Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Human Embryonic Stem Cells (HESC) Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Human Embryonic Stem Cells (HESC) Sales (K Units) by Type (2018-2023)

    Table 51. Global Human Embryonic Stem Cells (HESC) Sales (K Units) by Type (2024-2029)

    Table 52. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2018-2023)

    Table 53. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2024-2029)

    Table 54. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2018-2023)

    Table 57. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2024-2029)

    Table 58. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Human Embryonic Stem Cells (HESC) Sales (K Units) by Application (2018-2023)

    Table 61. Global Human Embryonic Stem Cells (HESC) Sales (K Units) by Application (2024-2029)

    Table 62. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2018-2023)

    Table 63. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2024-2029)

    Table 64. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2018-2023)

    Table 67. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2024-2029)

    Table 68. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Application (2024-2029)

    Table 70. ESI BIO Corporation Information

    Table 71. ESI BIO Description and Business Overview

    Table 72. ESI BIO Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. ESI BIO Human Embryonic Stem Cells (HESC) Product

    Table 74. ESI BIO Recent Developments/Updates

    Table 75. Thermo Fisher Corporation Information

    Table 76. Thermo Fisher Description and Business Overview

    Table 77. Thermo Fisher Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Thermo Fisher Human Embryonic Stem Cells (HESC) Product

    Table 79. Thermo Fisher Recent Developments/Updates

    Table 80. BioTime Corporation Information

    Table 81. BioTime Description and Business Overview

    Table 82. BioTime Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. BioTime Human Embryonic Stem Cells (HESC) Product

    Table 84. BioTime Recent Developments/Updates

    Table 85. MilliporeSigma (Merck) Corporation Information

    Table 86. MilliporeSigma (Merck) Description and Business Overview

    Table 87. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product

    Table 89. MilliporeSigma (Merck) Recent Developments/Updates

    Table 90. BD Biosciences Corporation Information

    Table 91. BD Biosciences Description and Business Overview

    Table 92. BD Biosciences Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. BD Biosciences Human Embryonic Stem Cells (HESC) Product

    Table 94. BD Biosciences Recent Developments/Updates

    Table 95. Astellas Institute of Regenerative Medicine Corporation Information

    Table 96. Astellas Institute of Regenerative Medicine Description and Business Overview

    Table 97. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product

    Table 99. Astellas Institute of Regenerative Medicine Recent Developments/Updates

    Table 100. Asterias Biotherapeutics Corporation Information

    Table 101. Asterias Biotherapeutics Description and Business Overview

    Table 102. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product

    Table 104. Asterias Biotherapeutics Recent Developments/Updates

    Table 105. PerkinElmer Corporation Information

    Table 106. PerkinElmer Description and Business Overview

    Table 107. PerkinElmer Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. PerkinElmer Human Embryonic Stem Cells (HESC) Product

    Table 109. PerkinElmer Recent Developments/Updates

    Table 110. Takara Bio Corporation Information

    Table 111. Takara Bio Description and Business Overview

    Table 112. Takara Bio Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. Takara Bio Human Embryonic Stem Cells (HESC) Product

    Table 114. Takara Bio Recent Developments/Updates

    Table 115. Fujifilm Cellular Dynamics Corporation Information

    Table 116. Fujifilm Cellular Dynamics Description and Business Overview

    Table 117. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product

    Table 119. Fujifilm Cellular Dynamics Recent Developments/Updates

    Table 120. Reliance Life Sciences Corporation Information

    Table 121. Reliance Life Sciences Description and Business Overview

    Table 122. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 123. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product

    Table 124. Reliance Life Sciences Recent Developments/Updates

    Table 125. R&D Systems (Biotrchne) Corporation Information

    Table 126. R&D Systems (Biotrchne) Description and Business Overview

    Table 127. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 128. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product

    Table 129. R&D Systems (Biotrchne) Recent Developments/Updates

    Table 130. STEMCELL Technologies Corporation Information

    Table 131. STEMCELL Technologies Description and Business Overview

    Table 132. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 133. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product

    Table 134. STEMCELL Technologies Recent Developments/Updates

    Table 135. TATAA Biocenter Corporation Information

    Table 136. TATAA Biocenter Description and Business Overview

    Table 137. TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 138. TATAA Biocenter Human Embryonic Stem Cells (HESC) Product

    Table 139. TATAA Biocenter Recent Developments/Updates

    Table 140. UK Stem Cell Bank Corporation Information

    Table 141. UK Stem Cell Bank Description and Business Overview

    Table 142. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 143. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product

    Table 144. UK Stem Cell Bank Recent Developments/Updates

    Table 145. Viacyte, Inc. Corporation Information

    Table 146. Viacyte, Inc. Description and Business Overview

    Table 147. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 148. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product

    Table 149. Viacyte, Inc. Recent Developments/Updates

    Table 150. Key Raw Materials Lists

    Table 151. Raw Materials Key Suppliers Lists

    Table 152. Human Embryonic Stem Cells (HESC) Distributors List

    Table 153. Human Embryonic Stem Cells (HESC) Customers List

    Table 154. Human Embryonic Stem Cells (HESC) Market Trends

    Table 155. Human Embryonic Stem Cells (HESC) Market Drivers

    Table 156. Human Embryonic Stem Cells (HESC) Market Challenges

    Table 157. Human Embryonic Stem Cells (HESC) Market Restraints

    Table 158. Research Programs/Design for This Report

    Table 159. Key Data Information from Secondary Sources

    Table 160. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Human Embryonic Stem Cells (HESC)

    Figure 2. Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Human Embryonic Stem Cells (HESC) Market Share by Type in 2022 & 2029

    Figure 4. Totipotent Stem Cells Product Picture

    Figure 5. Pluripotent Stem Cells Product Picture

    Figure 6. Unipotent Stem Cells Product Picture

    Figure 7. Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Human Embryonic Stem Cells (HESC) Market Share by Application in 2022 & 2029

    Figure 9. Research

    Figure 10. Clinical Trials

    Figure 11. Others

    Figure 12. Global Human Embryonic Stem Cells (HESC) Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Human Embryonic Stem Cells (HESC) Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Human Embryonic Stem Cells (HESC) Sales (2018-2029) & (K Units)

    Figure 15. Global Human Embryonic Stem Cells (HESC) Average Price (USD/Unit) & (2018-2029)

    Figure 16. Human Embryonic Stem Cells (HESC) Report Years Considered

    Figure 17. Human Embryonic Stem Cells (HESC) Sales Share by Manufacturers in 2022

    Figure 18. Global Human Embryonic Stem Cells (HESC) Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Human Embryonic Stem Cells (HESC) Players: Market Share by Revenue in 2022

    Figure 20. Human Embryonic Stem Cells (HESC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Human Embryonic Stem Cells (HESC) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2018-2029)

    Figure 23. North America Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2018-2029)

    Figure 27. Europe Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2018-2029)

    Figure 35. China Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Taiwan Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Philippines Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. UAE Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Human Embryonic Stem Cells (HESC) by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Human Embryonic Stem Cells (HESC) by Type (2018-2029)

    Figure 57. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Human Embryonic Stem Cells (HESC) by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Human Embryonic Stem Cells (HESC) by Application (2018-2029)

    Figure 60. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Application (2018-2029)

    Figure 61. Human Embryonic Stem Cells (HESC) Value Chain

    Figure 62. Human Embryonic Stem Cells (HESC) Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed